Zihe Liu – Trademark Portfolio

Entity Type: 01

Zihe Liu holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include GREABBY, GREABRRY, and QUITEDEW. The owner is based in Shizuishan City.

No. 2, Building 15, Wenya Lane

Wenming South Road, Dawukou District

Shizuishan City 753000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GREABBY
GREABBY
Registered 2020
GREABRRY
GREABRRY
Registered 2020
QUITEDEW
QUITEDEW
Registered 2020

Trademark Classifications

Zihe Liu's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

16
Paper Goods (2 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Zihe Liu have?

Zihe Liu has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Zihe Liu file in?

Zihe Liu files trademarks across 2 Nice Classification classes. The most active classes are Class 16 (Paper Goods), Class 5 (Pharmaceuticals). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.

What are Zihe Liu's most well-known trademarks?

Zihe Liu's registered trademark portfolio includes well-known marks such as GREABBY, GREABRRY, and QUITEDEW. These are among 3 currently registered trademarks in the portfolio.

What is Zihe Liu's trademark registration success rate?

Zihe Liu has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.